Trial Profile
A Randomised, Double-blind Study in Healthy Volunteers to Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar disorders; Epilepsy
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 22 Apr 2015 New trial record